Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Amplified fragment length polymorphism and whole genome sequencing: a comparison of methods in the investigation of a nosocomial outbreak with vancomycin resistant enterococci.

Janes VA, Notermans DW, Spijkerman IJB, Visser CE, Jakobs ME, van Houdt R, Willems RJL, de Jong MD, Schultsz C, Matamoros S.

Antimicrob Resist Infect Control. 2019 Sep 23;8:153. doi: 10.1186/s13756-019-0604-5. eCollection 2019.

2.

Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.

de Heer K, Gerritsen MG, Visser CE, Leeflang MM.

Cochrane Database Syst Rev. 2019 May 20;5:CD012399. doi: 10.1002/14651858.CD012399.pub2.

PMID:
31107543
3.

Carriage of antibiotic-resistant Gram-negative bacteria after discontinuation of selective decontamination of the digestive tract (SDD) or selective oropharyngeal decontamination (SOD).

de Jonge E, de Wilde RBP, Juffermans NP, Oostdijk EAN, Bernards AT, van Essen EHR, Kuijper EJ, Visser CE, Kesecioglu J, Bonten MJM.

Crit Care. 2018 Sep 29;22(1):243. doi: 10.1186/s13054-018-2170-2.

4.

Neutrophil extracellular traps in patients with pulmonary tuberculosis.

van der Meer AJ, Zeerleder S, Blok DC, Kager LM, Lede IO, Rahman W, Afroz R, Ghose A, Visser CE, Zahed ASM, Husain MA, Alam KM, Barua PC, Hassan M, Tayab MA, Dondorp AM, van der Poll T.

Respir Res. 2017 Oct 30;18(1):181. doi: 10.1186/s12931-017-0663-1.

5.

In Vitro Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents.

Koetsveld J, Draga ROP, Wagemakers A, Manger A, Oei A, Visser CE, Hovius JW.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00535-17. doi: 10.1128/AAC.00535-17. Print 2017 Sep.

6.

Profiling of volatile organic compounds produced by clinical Aspergillus isolates using gas chromatography-mass spectrometry.

Gerritsen MG, Brinkman P, Escobar N, Bos LD, de Heer K, Meijer M, Janssen HG, de Cock H, Wösten HAB, Visser CE, van Oers MHJ, Sterk PJ.

Med Mycol. 2018 Feb 1;56(2):253-256. doi: 10.1093/mmy/myx035.

PMID:
28525576
7.

Selective decontamination of the digestive tract halves the prevalence of ventilator-associated pneumonia compared to selective oral decontamination.

Bos LD, Stips C, Schouten LR, van Vught LA, Wiewel MA, Wieske L, van Hooijdonk RT, Straat M, de Beer FM, Glas GJ, Visser CE, de Jonge E, Juffermans NP, Horn J, Schultz MJ.

Intensive Care Med. 2017 Oct;43(10):1535-1537. doi: 10.1007/s00134-017-4838-5. Epub 2017 May 11. No abstract available.

PMID:
28497272
8.

Antimicrobial prophylaxis outside the operating theatre, an audit in a university hospital.

Deelen JWT, Visser CE, Prins JM, van Hest RM.

BMC Infect Dis. 2017 Apr 21;17(1):296. doi: 10.1186/s12879-017-2354-4.

9.

Notice of Retraction and Replacement: Oostdijk et al. Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs: A Randomized Clinical Trial. JAMA. 2014;312(14):1429-1437.

Oostdijk EAN, Kesecioglu J, Schultz MJ, Visser CE, de Jonge E, van Essen EHR, Bernards AT, Purmer I, Brimicombe R, Bergmans D, van Tiel F, Bosch FH, Mascini E, van Griethuysen A, Bindels A, Jansz A, van Steveninck FAL, van der Zwet WC, Fijen JW, Thijsen S, de Jong R, Oudbier J, Raben A, van der Vorm E, Koeman M, Rothbarth P, Rijkeboer A, Gruteke P, Hart H, Peerbooms P, Winsser LJ, van Elsacker-Niele AW, Demmendaal K, Brandenburg A, de Smet AMGA, Bonten MJM.

JAMA. 2017 Apr 18;317(15):1583-1584. doi: 10.1001/jama.2017.1282. No abstract available.

PMID:
28418487
10.

Effect of an antibiotic checklist on length of hospital stay and appropriate antibiotic use in adult patients treated with intravenous antibiotics: a stepped wedge cluster randomized trial.

van Daalen FV, Prins JM, Opmeer BC, Boermeester MA, Visser CE, van Hest RM, Branger J, Mattsson E, van de Broek MFM, Roeleveld TC, Karimbeg AA, Haak EAF, van den Hout HC, van Agtmael MA, Hulscher MEJL, Geerlings SE.

Clin Microbiol Infect. 2017 Jul;23(7):485.e1-485.e8. doi: 10.1016/j.cmi.2017.01.019. Epub 2017 Jan 31.

11.

eNose technology can detect and classify human pathogenic molds in vitro: a proof-of-concept study of Aspergillus fumigatus and Rhizopus oryzae.

de Heer K, Vonk SI, Kok M, Kolader M, Zwinderman AH, van Oers MH, Sterk PJ, Visser CE.

J Breath Res. 2016 Jul 22;10(3):036008. doi: 10.1088/1752-7155/10/3/036008.

PMID:
27447026
12.

Correction for de Heer et al., Detection of Airway Colonization by Aspergillus fumigatus by Use of Electronic Nose Technology in Patients with Cystic Fibrosis.

de Heer K, Kok MGM, Fens N, Weersink EJM, Zwinderman AH, van der Schee MPC, Visser CE, van Oers MHJ, Sterk PJ.

J Clin Microbiol. 2016 Jul;54(7):1926. doi: 10.1128/JCM.00748-16. No abstract available.

13.

Galactomannan detection for invasive aspergillosis in immunocompromised patients.

Leeflang MM, Debets-Ossenkopp YJ, Wang J, Visser CE, Scholten RJ, Hooft L, Bijlmer HA, Reitsma JB, Zhang M, Bossuyt PM, Vandenbroucke-Grauls CM.

Cochrane Database Syst Rev. 2015 Dec 30;(12):CD007394. doi: 10.1002/14651858.CD007394.pub2. Review.

14.

Detection of Airway Colonization by Aspergillus fumigatus by Use of Electronic Nose Technology in Patients with Cystic Fibrosis.

de Heer K, Kok MG, Fens N, Weersink EJ, Zwinderman AH, van der Schee MP, Visser CE, van Oers MH, Sterk PJ.

J Clin Microbiol. 2016 Mar;54(3):569-75. doi: 10.1128/JCM.02214-15. Epub 2015 Dec 16. Erratum in: J Clin Microbiol. 2016 Jul;54(7):1926.

15.

Cost-effectiveness in Clostridium difficile treatment decision-making.

Nuijten MJ, Keller JJ, Visser CE, Redekop K, Claassen E, Speelman P, Pronk MH.

World J Clin Cases. 2015 Nov 16;3(11):935-41. doi: 10.12998/wjcc.v3.i11.935.

16.

Soluble and cell-associated triggering receptor expressed on myeloid cells-1 and -2 in patients with pulmonary tuberculosis.

Hoogendijk AJ, Blok DC, Garcia Laorden MI, Kager LM, Lede IO, Rahman W, Afroz R, Bresser P, van der Zee JS, Ghose A, Visser CE, de Jong MD, Zahed AS, Husain MA, Alam KM, Barua PC, Hassan M, Hossain A, Tayab MA, Lutter R, Day N, Dondorp AM, Van't Veer C, de Vos AF, van der Poll T.

J Infect. 2015 Dec;71(6):706-9. doi: 10.1016/j.jinf.2015.09.002. Epub 2015 Sep 15. No abstract available.

PMID:
26384438
17.

Changes in microbiota during experimental human Rhinovirus infection.

Hofstra JJ, Matamoros S, van de Pol MA, de Wever B, Tanck MW, Wendt-Knol H, Deijs M, van der Hoek L, Wolthers KC, Molenkamp R, Visser CE, Sterk PJ, Lutter R, de Jong MD.

BMC Infect Dis. 2015 Aug 14;15:336. doi: 10.1186/s12879-015-1081-y.

18.

Increased intra- and extracellular granzyme expression in patients with tuberculosis.

Garcia-Laorden MI, Blok DC, Kager LM, Hoogendijk AJ, van Mierlo GJ, Lede IO, Rahman W, Afroz R, Ghose A, Visser CE, Md Zahed AS, Husain MA, Alam KM, Chandra Barua P, Hassan M, Hossain A, Tayab MA, Day N, Dondorp AM, de Vos AF, van der Poll T.

Tuberculosis (Edinb). 2015 Sep;95(5):575-80. doi: 10.1016/j.tube.2015.05.016. Epub 2015 Jun 20.

PMID:
26156785
19.

A cluster randomized trial for the implementation of an antibiotic checklist based on validated quality indicators: the AB-checklist.

van Daalen FV, Prins JM, Opmeer BC, Boermeester MA, Visser CE, van Hest RM, Hulscher ME, Geerlings SE.

BMC Infect Dis. 2015 Mar 19;15:134. doi: 10.1186/s12879-015-0867-2.

20.

Expression of inhibitory regulators of innate immunity in patients with active tuberculosis.

Blok DC, Kager LM, Hoogendijk AJ, Lede IO, Rahman W, Afroz R, Bresser P, van der Zee JS, Ghose A, Visser CE, de Jong MD, Zahed AS, Husain MA, Alam KM, Barua PC, Hassan M, Hossain A, Tayab MA, Lutter R, Day N, Dondorp AM, de Vos AF, van 't Veer C, van der Poll T.

BMC Infect Dis. 2015 Feb 26;15:98. doi: 10.1186/s12879-015-0833-z.

21.

Clinical, environmental, and serologic surveillance studies of melioidosis in Gabon, 2012-2013.

Wiersinga WJ, Birnie E, Weehuizen TA, Alabi AS, Huson MA, Huis in 't Veld RA, Mabala HK, Adzoda GK, Raczynski-Henk Y, Esen M, Lell B, Kremsner PG, Visser CE, Wuthiekanun V, Peacock SJ, van der Ende A, Limmathurotsakul D, Grobusch MP.

Emerg Infect Dis. 2015 Jan;21(1):40-7. doi: 10.3201/eid2101.140762.

22.

Pulmonary tuberculosis induces a systemic hypercoagulable state.

Kager LM, Blok DC, Lede IO, Rahman W, Afroz R, Bresser P, van der Zee JS, Ghose A, Visser CE, de Jong MD, Tanck MW, Zahed AS, Alam KM, Hassan M, Hossain A, Lutter R, Veer CV, Dondorp AM, Meijers JC, van der Poll T.

J Infect. 2015 Apr;70(4):324-34. doi: 10.1016/j.jinf.2014.10.006. Epub 2014 Oct 29.

PMID:
25455017
23.

Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: a randomized clinical trial.

Oostdijk EAN, Kesecioglu J, Schultz MJ, Visser CE, de Jonge E, van Essen EHR, Bernards AT, Purmer I, Brimicombe R, Bergmans D, van Tiel F, Bosch FH, Mascini E, van Griethuysen A, Bindels A, Jansz A, van Steveninck FAL, van der Zwet WC, Fijen JW, Thijsen S, de Jong R, Oudbier J, Raben A, van der Vorm E, Koeman M, Rothbarth P, Rijkeboer A, Gruteke P, Hart-Sweet H, Peerbooms P, Winsser LJ, van Elsacker-Niele AW, Demmendaal K, Brandenburg A, de Smet AMGA, Bonten MJM.

JAMA. 2014 Oct 8;312(14):1429-1437. doi: 10.1001/jama.2014.7247.

PMID:
25271544
24.

Performance of Kiestra total laboratory automation combined with MS in clinical microbiology practice.

Mutters NT, Hodiamont CJ, de Jong MD, Overmeijer HP, van den Boogaard M, Visser CE.

Ann Lab Med. 2014 Mar;34(2):111-7. doi: 10.3343/alm.2014.34.2.111. Epub 2014 Feb 13.

25.

[Necrotising soft-tissue infections: diagnostics and treatment].

Garssen FP, Goslings JC, Bouman CS, Beenen LF, Visser CE, de Jong VM.

Ned Tijdschr Geneeskd. 2013;157(31):A6031. Review. Dutch.

PMID:
23899705
26.

Febrile neutropenia: significance of elaborated screening for respiratory viruses, and the comparison of different sampling methods, in neutropenic patients with hematological malignancies.

Jansen RR, Biemond BJ, Schinkel J, Koekkoek SM, Molenkamp R, de Jong MD, Visser CE.

Virol J. 2013 Jun 27;10:212. doi: 10.1186/1743-422X-10-212.

27.

Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study.

de Heer K, van der Schee MP, Zwinderman K, van den Berk IA, Visser CE, van Oers R, Sterk PJ.

J Clin Microbiol. 2013 May;51(5):1490-5. doi: 10.1128/JCM.02838-12. Epub 2013 Mar 6.

28.

Contamination rates of three urine-sampling methods to assess bacteriuria in pregnant women.

Schneeberger C, van den Heuvel ER, Erwich JJ, Stolk RP, Visser CE, Geerlings SE.

Obstet Gynecol. 2013 Feb;121(2 Pt 1):299-305. doi: http://10.1097/AOG.0b013e31827e8cfe.

PMID:
23344279
29.

Duodenal infusion of donor feces for recurrent Clostridium difficile.

van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG, Speelman P, Dijkgraaf MG, Keller JJ.

N Engl J Med. 2013 Jan 31;368(5):407-15. doi: 10.1056/NEJMoa1205037. Epub 2013 Jan 16.

30.

An unexpected cause of multiple intra-abdominal abscesses in an HIV-positive patient.

van der Spek AH, Vosters JL, Visser CE, van der Valk M, Nellen JF.

Neth J Med. 2012 May;70(4):190-2.

31.

Rapid diagnostic testing of methicillin-resistant Staphylococcus aureus carriage at different anatomical sites: costs and benefits of less extensive screening regimens.

Wassenberg MW, Kluytmans JA, Bosboom RW, Buiting AG, van Elzakker EP, Melchers WJ, Thijsen SF, Troelstra A, Vandenbroucke-Grauls CM, Visser CE, Voss A, Wolffs PF, Wulf MW, van Zwet AA, de Wit GA, Bonten MJ.

Clin Microbiol Infect. 2011 Nov;17(11):1704-10. doi: 10.1111/j.1469-0691.2011.03502.x. Epub 2011 May 20.

32.

Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values.

Jansen RR, Wieringa J, Koekkoek SM, Visser CE, Pajkrt D, Molenkamp R, de Jong MD, Schinkel J.

J Clin Microbiol. 2011 Jul;49(7):2631-6. doi: 10.1128/JCM.02094-10. Epub 2011 May 4.

33.

18F-fluoro-2-deoxyglucose positron emission tomography-negative endocarditis lenta caused by Bartonella henselae.

Sankatsing SU, Kolader ME, Bouma BJ, Bennink RJ, Verberne HJ, Ansink TM, Visser CE, van der Meer JT.

J Heart Valve Dis. 2011 Jan;20(1):100-2.

PMID:
21404906
34.

Seroepidemiological studies indicate frequent and repeated exposure to Campylobacter spp. during childhood.

Ang CW, Teunis PF, Herbrink P, Keijser J, Van Duynhoven YH, Visser CE, Van Pelt W.

Epidemiol Infect. 2011 Sep;139(9):1361-8. doi: 10.1017/S0950268810002359. Epub 2010 Oct 26.

PMID:
20974019
35.

Rapid screening of methicillin-resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effects.

Wassenberg MW, Kluytmans JA, Box AT, Bosboom RW, Buiting AG, van Elzakker EP, Melchers WJ, van Rijen MM, Thijsen SF, Troelstra A, Vandenbroucke-Grauls CM, Visser CE, Voss A, Wolffs PF, Wulf MW, van Zwet AA, de Wit GA, Bonten MJ.

Clin Microbiol Infect. 2010 Dec;16(12):1754-61. doi: 10.1111/j.1469-0691.2010.03210.x.

36.

Quantitation of respiratory viruses in relation to clinical course in children with acute respiratory tract infections.

Jansen RR, Schinkel J, Dek I, Koekkoek SM, Visser CE, de Jong MD, Molenkamp R, Pajkrt D.

Pediatr Infect Dis J. 2010 Jan;29(1):82-4. doi: 10.1097/INF.0b013e3181b6de8a.

PMID:
19858770
37.

Asymptomatic carriage of Clostridium difficile among HCWs: Do we disregard the doctor?

van Nood E, van Dijk K, Hegeman Z, Speelman P, Visser CE.

Infect Control Hosp Epidemiol. 2009 Sep;30(9):924-5. doi: 10.1086/605642. No abstract available.

PMID:
19653823
38.

Azole-resistant central nervous system aspergillosis.

van der Linden JW, Jansen RR, Bresters D, Visser CE, Geerlings SE, Kuijper EJ, Melchers WJ, Verweij PE.

Clin Infect Dis. 2009 Apr 15;48(8):1111-3. doi: 10.1086/597465.

PMID:
19272019
39.

Galactomannan detection for invasive aspergillosis in immunocompromized patients.

Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Scholten RJ, Hooft L, Bijlmer HA, Reitsma JB, Bossuyt PM, Vandenbroucke-Grauls CM.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD007394. doi: 10.1002/14651858.CD007394. Review. Update in: Cochrane Database Syst Rev. 2015;12:CD007394.

PMID:
18843747
40.

[Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces].

Nieuwdorp M, van Nood E, Speelman P, van Heukelem HA, Jansen JM, Visser CE, Kuijper EJ, Bartelsman JF, Keller JJ.

Ned Tijdschr Geneeskd. 2008 Aug 30;152(35):1927-32. Dutch.

PMID:
18808083
41.

Invasive infections with a coagulase-negative staphylococcus in an immunocompromised patient: case report and review of the literature.

Choi G, van den Borne MP, Visser CE, Kersten MJ, Kater AP.

Ann Hematol. 2008 Sep;87(9):771-2. doi: 10.1007/s00277-008-0476-x. Epub 2008 Apr 3. No abstract available.

42.

Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005.

Paltansing S, van den Berg RJ, Guseinova RA, Visser CE, van der Vorm ER, Kuijper EJ.

Clin Microbiol Infect. 2007 Nov;13(11):1058-64.

43.

Validation of an ELISA for the diagnosis of recent Campylobacter infections in Guillain-Barré and reactive arthritis patients.

Ang CW, Krogfelt K, Herbrink P, Keijser J, van Pelt W, Dalby T, Kuijf M, Jacobs BC, Bergman MP, Schiellerup P, Visser CE.

Clin Microbiol Infect. 2007 Sep;13(9):915-22. Epub 2007 Jul 30.

44.

Identification of genotypically diverse Cryptococcus neoformans and Cryptococcus gattii isolates by Luminex xMAP technology.

Bovers M, Diaz MR, Hagen F, Spanjaard L, Duim B, Visser CE, Hoogveld HL, Scharringa J, Hoepelman IM, Fell JW, Boekhout T.

J Clin Microbiol. 2007 Jun;45(6):1874-83. Epub 2007 Apr 18.

45.

An outbreak of psittacosis due to Chlamydophila psittaci genotype A in a veterinary teaching hospital.

Heddema ER, van Hannen EJ, Duim B, de Jongh BM, Kaan JA, van Kessel R, Lumeij JT, Visser CE, Vandenbroucke-Grauls CM.

J Med Microbiol. 2006 Nov;55(Pt 11):1571-5.

PMID:
17030918
46.

Meta-analysis of diagnostic test accuracy.

Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Bossuyt PM.

Clin Infect Dis. 2006 Nov 1;43(9):1220; author reply 1220-1. No abstract available.

PMID:
17029148
47.

Prevalence of Chlamydophila psittaci in fecal droppings from feral pigeons in Amsterdam, The Netherlands.

Heddema ER, Ter Sluis S, Buys JA, Vandenbroucke-Grauls CM, van Wijnen JH, Visser CE.

Appl Environ Microbiol. 2006 Jun;72(6):4423-5.

48.

Clostridium difficile ribotype 027, toxinotype III, the Netherlands.

Kuijper EJ, van den Berg RJ, Debast S, Visser CE, Veenendaal D, Troelstra A, van der Kooi T, van den Hof S, Notermans DW.

Emerg Infect Dis. 2006 May;12(5):827-30.

49.

[Life-threatening infections with a new strain of Clostridium difficile].

Krausz S, Bessems M, Boermeester MA, Kuijper EJ, Visser CE, Speelman P.

Ned Tijdschr Geneeskd. 2005 Sep 17;149(38):2081-6. Dutch.

PMID:
16201595
50.

Changing epidemiology of melioidosis? A case of acute pulmonary melioidosis with fatal outcome imported from Brazil.

Aardema H, Luijnenburg EM, Salm EF, Bijlmer HA, Visser CE, Van't Wout JW.

Epidemiol Infect. 2005 Oct;133(5):871-5.

Supplemental Content

Loading ...
Support Center